Background Evaluate the effectiveness and response Gastric balloon ( Lexbal ) in the treatment of mild to moderate obesity Observational and retrospective Introduction Descriptive observational study in which the sample is made up of the 12 patients treated with balloon LEXBAL The variables studied were age , sex, weight , BMI, percentage of weight lost , fill volume , tolerance, satisfaction Objectives Evaluate the effectiveness and response balloon ( Lexbal ) in the treatment of mild to moderate obesity Methods We conducted in Hospital Paroissien an observational, retrospective study . We have compiled the results of 12 follow intragastric balloons (Balon Lexbal ) in obese patients with mild to moderate type I- II (BMI between 28 and 34.9 kg/m2 ) placed in 2012 and 2016 losses have been achieved over 70 % of excess weight The variables studied were age sex, weight BMI,% of weight lost ,fill volume,tolerance, satisfaction and dietary monitoring Results Over 80 % degree of patient satisfaction , 70 % decrease in weight above the average ( over 12 kilos ) better response in those presenting adherence to nutritional treatment and no differences were observed in the volume of filling the balloon Conclusion Treatment with intragastric balloon, along with a nutritional monitoring allows us to re-educate the patient, and change their eating habits. • Just for gradual diet, and to adapt each phase as tolerated by the patient, helps us to improve dietary behavior and facilitates greater weight loss The IG ballon is a safe, well tolerated, with few adverse effects
Gastroenterology Registrar for Dr. Martin Buckley, Mercy University Hospital
BACKGROUND: With the beginning of 21th century, the development of Wireless Video Capsule (WVC) caused a breakthrough in the intraluminal visualization of the entire small bowel in a well- tolerated and non- invasive way. It has enhanced the diagnostic gap between conventional gastroscopy and colonoscopy1. AIM: Compare MRE and WVC in detecting small bowel involvement in previously diagnosed CD and or suspected small bowel CD. Methodology: An observational cohort study conducted in Mercy University Hospital from January 2016 until August 2017. The recruited patients were patients referred for WVC with either established CD and/or suspected small bowel CD. All cases referred with suggestive clinical symptoms such as (diarrhoea, abdominal pain, weight loss and iron deficiency anemia) and biochemical signs of systemic inflammation (raised CRP/fecal calprotectine). A standardized work-up including blood and stool samples, gastroscopy, ileocolonoscopy and MRE were performed to all included patients. WVC performed in patients with no stenosis detected on ileocolonoscopy and MRE. Exclusion criteria were patient who had no MRE in 2016. RESULTS: Total of 20 patients were recruited, (13 female), aged 19-74 years (mean age 44). Of the 20 patients, 8 patients were established IBD and 12 patients with suspicion of small bowel CD. Out of 12 patients with suspected small bowel CD, only 8 patients had small bowel pathology detected radiologically. 4 patients (50 %) had positive WVC, one patient ( 12.5%) had positive MRE and 3 patients (37.5%) had positive WCV and MRE. In all IBD patients, small bowel pathology detected with WCV (100%). 2 out of 8 patients with IBD (25%), small bowel pathologies detected in both MRE and WVC In Conclusion Small bowel imaging is an essential component in diagnosing, monitoring and treating small bowel CD and suspected small bowel pathology. Both MRE and WVC are complementary methods for small bowel CD. VCE is more capable of detecting limited mucosal lesions that may be missed by MRE.